AXIM Biotechnologies, Inc. (AXIM)

AXIM Biotechnologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-8.06	-5.96	-16.52	-6.73	-6.77
Depreciation & Amortization	0.43	0.43	2.12	0.02	0.01
Share-Based Compensation	0.2	1.11	1.14	2.31	1.84
Other Operating Activities	6.4	2.38	10.77	1.19	-0.09
Operating Cash Flow	-1.03	-2.04	-2.49	-3.22	-5.02
Capital Expenditures	0	-0.01	-0.05	-0.1	0
Acquisitions	0	0	0	0.08	-0.03
Change in Investments	-	-	-	-	-0.38
Other Investing Activities	-	-	-	0.03	0.75
Investing Cash Flow	0	-0.01	-0.05	0.01	0.35
Common Stock Issued	0.49	1.74	1.64	3.31	3.46
Share Repurchases	0.15	0	25,000	0	0
Other Financing Activities	0.8	-0.09	25,001	-0.16	-0.09
Financing Cash Flow	1.14	1.65	2.53	3.15	3.38
Net Cash Flow	0.11	-0.41	-0	-0.05	-1.29
Free Cash Flow	-1.03	-2.05	-2.54	-3.31	-5.02
Free Cash Flow Margin	-2607.67%	-23132.80%	-4196.59%	-	-627.92%
Free Cash Flow Per Share	-0.00	-0.01	-0.02	-0.03	-0.08

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.